|1.||Jayakumar, R: 4 articles (12/2014 - 07/2012)|
|2.||Nair, Shantikumar V: 3 articles (04/2013 - 07/2012)|
|3.||Periayah, Mercy Halleluyah: 2 articles (09/2015 - 01/2015)|
|4.||Halim, Ahmad Sukari: 2 articles (09/2015 - 01/2015)|
|5.||Yaacob, Nik Soriani: 2 articles (09/2015 - 01/2015)|
|6.||Hussein, Abdul Rahim: 2 articles (09/2015 - 01/2015)|
|7.||Ujang, Zanariah: 2 articles (09/2015 - 01/2015)|
|8.||Snima, K S: 2 articles (12/2014 - 07/2012)|
|9.||Lakshmanan, Vinoth-Kumar: 2 articles (12/2014 - 07/2012)|
|10.||Maya, S: 2 articles (04/2013 - 11/2012)|
04/02/2013 - "Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells."
06/04/2012 - "In this study, we developed a tumor-targeting delivery system for insoluble drug (paclitaxel, PTX) by PEGylated O-carboxymethyl-chitosan (CMC) nanoparticles grafted with cyclic Arg-Gly-Asp (RGD) peptide. "
11/01/2015 - "To produce a tumor-targeting nanophotosensitizer with near-infrared excitation, NaYF4:Yb/Er upconversion nanoparticles were first wrapped with O-carboxymethyl chitosan to develop an upconversion rianoplatform and then chemically conjugated with the photosensitizer pyropheophorbide-a (Ppa) and RGD peptide c(RGDyK). "
04/02/2013 - "The objective of this study was to develop a drug delivery system comprising O-carboxymethyl chitosan (O-CMC) nanoparticles, surface-conjugated with Cetuximab (Cet) for targeted delivery of paclitaxel (PTXL) to Epidermal Growth Factor Receptor (EGFR) over-expressing cancer cells. "
|3.||von Willebrand Diseases (von Willebrand's Disease)
09/01/2015 - "Effect of the Novel Biodegradable N, O-Carboxymethylchitosan and Oligo-Chitosan on the Platelet Thrombogenicity Cascade in von Willebrand Disease."
01/01/2015 - "This study investigated platelet morphology changes and the expression level of transforming growth factor-β1 (TGF-β1) and platelet-derived growth factor-AB (PDGF-AB) in the adherence of two different types of chitosans in von Willebrand disease (vWD): N,O-carboxymethylchitosan (NO-CMC) and oligo-chitosan (O-C). "
|4.||Lung Neoplasms (Lung Cancer)
|5.||Pancreatic Neoplasms (Pancreatic Cancer)
12/01/2014 - "In vitro anticancer effect and in vivo biodistribution and biocompatibility of metformin encapsulated O-Carboxymethyl chitosan nanoparticles were evaluated for its application as pancreatic cancer therapy. "
12/01/2014 - "In vitro and in vivo biological evaluation of O-carboxymethyl chitosan encapsulated metformin nanoparticles for pancreatic cancer therapy."
07/01/2012 - "O-carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells."
|5.||Epidermal Growth Factor Receptor (EGF Receptor)
|7.||platelet-derived growth factor AB
|9.||Glycyrrhizic Acid (Glycyrrhizin)
|10.||Anti-Infective Agents (Microbicides)